These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28258593)

  • 1. Hypertrophic Cardiomyopathy in Youth Athletes: Successful Screening With Point-of-Care Ultrasound by Medical Students.
    Fox JC; Lahham S; Maldonado G; Klaus S; Aish B; Sylwanowicz LV; Yanuck J; Wilson SP; Shieh M; Anderson CL; English C; Mayer R; Mohan UR
    J Ultrasound Med; 2017 Jun; 36(6):1109-1115. PubMed ID: 28258593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.
    Basavarajaiah S; Wilson M; Whyte G; Shah A; McKenna W; Sharma S
    J Am Coll Cardiol; 2008 Mar; 51(10):1033-9. PubMed ID: 18325444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes.
    Pelliccia A; Di Paolo FM; Corrado D; Buccolieri C; Quattrini FM; Pisicchio C; Spataro A; Biffi A; Granata M; Maron BJ
    Eur Heart J; 2006 Sep; 27(18):2196-200. PubMed ID: 16831826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot study analyzing automated ECG screening of hypertrophic cardiomyopathy.
    Campbell MJ; Zhou X; Han C; Abrishami H; Webster G; Miyake CY; Sower CT; Anderson JB; Knilans TK; Czosek RJ
    Heart Rhythm; 2017 Jun; 14(6):848-852. PubMed ID: 28193509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computerized Q wave dimensions in athletes and hypertrophic cardiomyopathy patients.
    Bent RE; Wheeler MT; Hadley D; Froelicher V; Ashley E; Perez MV
    J Electrocardiol; 2015; 48(3):362-7. PubMed ID: 25732098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in myocardial velocity gradient measured throughout the cardiac cycle in patients with hypertrophic cardiomyopathy, athletes and patients with left ventricular hypertrophy due to hypertension.
    Palka P; Lange A; Fleming AD; Donnelly JE; Dutka DP; Starkey IR; Shaw TR; Sutherland GR; Fox KA
    J Am Coll Cardiol; 1997 Sep; 30(3):760-8. PubMed ID: 9283537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hypertrophic cardiomyopathy on an electrocardiogram-based pre-participation screening programme in a young male South-East Asian population: results from the Singapore Armed Forces Electrocardiogram and Echocardiogram screening protocol.
    Ng CT; Chee TS; Ling LF; Lee YP; Ching CK; Chua TS; Cheok C; Ong HY
    Europace; 2011 Jun; 13(6):883-8. PubMed ID: 21486912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial ultrasound tissue characterization in patients with hypertrophic cardiomyopathy: noninvasive evidence of electrical and textural substrate for ventricular arrhythmias.
    Limongelli G; Pacileo G; Cerrato F; Verrengia M; Di Simone A; Severino S; Sarubbi B; Calabrò R
    J Am Soc Echocardiogr; 2003 Aug; 16(8):803-7. PubMed ID: 12878988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients.
    Biagini E; Coccolo F; Ferlito M; Perugini E; Rocchi G; Bacchi-Reggiani L; Lofiego C; Boriani G; Prandstraller D; Picchio FM; Branzi A; Rapezzi C
    J Am Coll Cardiol; 2005 Oct; 46(8):1543-50. PubMed ID: 16226182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Distinguishing between physiologic hypertrophy in athletes and primary hypertrophic cardiomyopathies. Importance of tissue color Doppler].
    Derumeaux G; Douillet R; Troniou A; Jamal F; Litzler PY; Pontier G; Cribier A
    Arch Mal Coeur Vaiss; 1999 Feb; 92(2):201-10. PubMed ID: 10078339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of suspected hypertrophic cardiomyopathy or left ventricular hypertrophy based on race and gender in teenagers using screening echocardiography.
    Movahed MR; Strootman D; Bates S; Sattur S
    Cardiovasc Ultrasound; 2010 Dec; 8():54. PubMed ID: 21143986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of intra-left ventricular electromechanical asynchrony in patients with mild hypertrophic cardiomyopathy compared with power athletes.
    D'Andrea A; Caso P; Cuomo S; Salerno G; Scarafile R; Mita C; De Corato G; Sarubbi B; Scherillo M; Calabrò R
    Br J Sports Med; 2006 Mar; 40(3):244-50; discussion 244-50. PubMed ID: 16505082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Progression of Late Gadolinium Enhancement in Children and Adolescents With Hypertrophic Cardiomyopathy.
    Axelsson Raja A; Farhad H; Valente AM; Couce JP; Jefferies JL; Bundgaard H; Zahka K; Lever H; Murphy AM; Ashley E; Day SM; Sherrid MV; Shi L; Bluemke DA; Canter CE; Colan SD; Ho CY
    Circulation; 2018 Aug; 138(8):782-792. PubMed ID: 29622585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early screening for cardiovascular abnormalities with preparticipation echocardiography: utility of focused physician-operated echocardiography in preparticipation screening of athletes.
    Yim ES; Basilico F; Corrado G
    J Ultrasound Med; 2014 Feb; 33(2):307-13. PubMed ID: 24449734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to "Hypertrophic Cardiomyopathy in Youth Athletes: Successful Screening With Point-of-Care Ultrasound by Medical Students".
    Kerkhof DL; Corrado GD
    J Ultrasound Med; 2018 Jun; 37(6):1575. PubMed ID: 29034497
    [No Abstract]   [Full Text] [Related]  

  • 16. Large Q and S waves in lead III on the electrocardiogram distinguish patients with hypertrophic cardiomyopathy from athletes.
    Chen AS; Bent RE; Wheeler M; Knowles JW; Haddad F; Froelicher V; Ashley E; Perez MV
    Heart; 2018 Nov; 104(22):1871-1877. PubMed ID: 29680808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrocardiographic abnormalities in elite high school athletes: comparison to adolescent hypertrophic cardiomyopathy.
    Thompson AJ; Cannon BC; Wackel PL; Horner JM; Ackerman MJ; O'Leary PW; Eidem BW; Johnson JN
    Br J Sports Med; 2016 Jan; 50(2):105-10. PubMed ID: 26729893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of various "classic" echocardiographic and laboratory indices in distinguishing the "gray zone" between athlete's heart and hypertrophic cardiomyopathy: a pilot study.
    Pagourelias ED; Efthimiadis GK; Kouidi E; Zorou P; Giannoglou G; Deligiannis A; Athyros VG; Karagiannis A; Geleris P
    Echocardiography; 2013 Feb; 30(2):131-9. PubMed ID: 23167844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early changes in apical rotation in genotype positive children with hypertrophic cardiomyopathy mutations without hypertrophic changes on two-dimensional imaging.
    Forsey J; Benson L; Rozenblyum E; Friedberg MK; Mertens L
    J Am Soc Echocardiogr; 2014 Feb; 27(2):215-21. PubMed ID: 24325958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of hypertrophic cardiomyopathy and screening for the phenotype suggestive of gene carriage in familial disease: a simple echocardiographic procedure.
    Devlin AM; Ostman-Smith I
    J Med Screen; 2000; 7(2):82-90. PubMed ID: 11002448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.